Kailera Therapeutics, Inc. (NASDAQ:KLRA) IPO
IPO
Priced at US$16.00 a share on Apr 16, 2026.
- Price
- US$16.00 a share
- Shares offered
- 39,062,500 shares of common stock
- Offering size
- US$625 million
- Underwriters' option
- Up to 5,859,375 more shares
- Listing
- KLRA on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Jefferies, Leerink Partners, TD Cowen, Evercore ISI, William Blair · In the order on the cover
- Shares delivered
- On or about Apr 20, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 19, 2025 |
| Filed publicly | Mar 27, 2026 |
| Amended once | Apr 13, 2026 |
| Shares registered with an exchange | Apr 14, 2026 |
| Declared effective by the SEC | Apr 16, 2026 |
| Final prospectus, with the price | Apr 17, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 17, 2026 |
| EFFECT · Notice that a registration is effective | Apr 16, 2026 |
| S-1MEF · Registration of more shares for the same offering | Apr 16, 2026 |
| CERT · Exchange's certificate of listing | Apr 15, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 14, 2026 |
| S-1/A · Registration statement, amended | Apr 13, 2026 |
| S-1 · Registration statement | Mar 27, 2026 |
| DRS/A · Draft registration statement, amended | Feb 11, 2026 |
| DRS · Draft registration statement | Dec 19, 2025 |
From the cover of the final prospectus (424B4) filed Apr 17, 2026